Effect of famotidine on cognitive and behavioral dysfunctions induced in post-COVID-19 infection: A randomized, double-blind, and placebo-controlled study

{ 'DOI': '10.1016/j.jpsychores.2023.111389', 'ISSN': ['0022-3999'], 'URL': 'http://dx.doi.org/10.1016/j.jpsychores.2023.111389', 'alternative-id': ['S0022399923002465'], 'article-number': '111389', 'assertion': [ {'label': 'This article is maintained by', 'name': 'publisher', 'value': 'Elsevier'}, { 'label': 'Article Title', 'name': 'articletitle', 'value': 'Effect of famotidine on cognitive and behavioral dysfunctions induced in ' 'post-COVID-19 infection: A randomized, double-blind, and placebo-controlled ' 'study'}, { 'label': 'Journal Title', 'name': 'journaltitle', 'value': 'Journal of Psychosomatic Research'}, { 'label': 'CrossRef DOI link to publisher maintained version', 'name': 'articlelink', 'value': 'https://doi.org/10.1016/j.jpsychores.2023.111389'}, {'label': 'Content Type', 'name': 'content_type', 'value': 'article'}, { 'label': 'Copyright', 'name': 'copyright', 'value': '© 2023 Elsevier Inc. All rights reserved.'}], 'author': [ {'affiliation': [], 'family': 'Momtazmanesh', 'given': 'Sara', 'sequence': 'first'}, {'affiliation': [], 'family': 'Ansari', 'given': 'Sahar', 'sequence': 'additional'}, {'affiliation': [], 'family': 'Izadi', 'given': 'Zahra', 'sequence': 'additional'}, {'affiliation': [], 'family': 'Shobeiri', 'given': 'Parnian', 'sequence': 'additional'}, {'affiliation': [], 'family': 'Vatankhah', 'given': 'Venus', 'sequence': 'additional'}, {'affiliation': [], 'family': 'Seifi', 'given': 'Arash', 'sequence': 'additional'}, {'affiliation': [], 'family': 'Ghiasvand', 'given': 'Fereshteh', 'sequence': 'additional'}, {'affiliation': [], 'family': 'Bahrami', 'given': 'Mahboobeh', 'sequence': 'additional'}, {'affiliation': [], 'family': 'Salehi', 'given': 'Mohammdreza', 'sequence': 'additional'}, {'affiliation': [], 'family': 'Noorbala', 'given': 'Ahmad Ali', 'sequence': 'additional'}, {'affiliation': [], 'family': 'Akhondzadeh', 'given': 'Shahin', 'sequence': 'additional'}], 'container-title': 'Journal of Psychosomatic Research', 'container-title-short': 'Journal of Psychosomatic Research', 'content-domain': { 'crossmark-restriction': True, 'domain': [ 'clinicalkey.fr', 'clinicalkey.jp', 'clinicalkey.com.au', 'clinicalkey.es', 'clinicalkey.com', 'elsevier.com', 'sciencedirect.com']}, 'created': {'date-parts': [[2023, 5, 31]], 'date-time': '2023-05-31T15:43:03Z', 'timestamp': 1685547783000}, 'deposited': { 'date-parts': [[2023, 7, 6]], 'date-time': '2023-07-06T05:33:05Z', 'timestamp': 1688621585000}, 'funder': [ { 'DOI': '10.13039/501100004484', 'award': ['52224'], 'doi-asserted-by': 'publisher', 'name': 'Tehran University of Medical Sciences and Health Services'}], 'indexed': {'date-parts': [[2023, 7, 6]], 'date-time': '2023-07-06T06:10:47Z', 'timestamp': 1688623847383}, 'is-referenced-by-count': 1, 'issued': {'date-parts': [[2023, 9]]}, 'language': 'en', 'license': [ { 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/', 'content-version': 'tdm', 'delay-in-days': 0, 'start': { 'date-parts': [[2023, 9, 1]], 'date-time': '2023-09-01T00:00:00Z', 'timestamp': 1693526400000}}, { 'URL': 'https://doi.org/10.15223/policy-017', 'content-version': 'stm-asf', 'delay-in-days': 0, 'start': { 'date-parts': [[2023, 9, 1]], 'date-time': '2023-09-01T00:00:00Z', 'timestamp': 1693526400000}}, { 'URL': 'https://doi.org/10.15223/policy-037', 'content-version': 'stm-asf', 'delay-in-days': 0, 'start': { 'date-parts': [[2023, 9, 1]], 'date-time': '2023-09-01T00:00:00Z', 'timestamp': 1693526400000}}, { 'URL': 'https://doi.org/10.15223/policy-012', 'content-version': 'stm-asf', 'delay-in-days': 0, 'start': { 'date-parts': [[2023, 9, 1]], 'date-time': '2023-09-01T00:00:00Z', 'timestamp': 1693526400000}}, { 'URL': 'https://doi.org/10.15223/policy-029', 'content-version': 'stm-asf', 'delay-in-days': 0, 'start': { 'date-parts': [[2023, 9, 1]], 'date-time': '2023-09-01T00:00:00Z', 'timestamp': 1693526400000}}, { 'URL': 'https://doi.org/10.15223/policy-004', 'content-version': 'stm-asf', 'delay-in-days': 0, 'start': { 'date-parts': [[2023, 9, 1]], 'date-time': '2023-09-01T00:00:00Z', 'timestamp': 1693526400000}}], 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S0022399923002465?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S0022399923002465?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'member': '78', 'original-title': [], 'page': '111389', 'prefix': '10.1016', 'published': {'date-parts': [[2023, 9]]}, 'published-print': {'date-parts': [[2023, 9]]}, 'publisher': 'Elsevier BV', 'reference': [ { 'DOI': '10.1016/j.virusres.2014.09.011', 'article-title': 'Human coronaviruses: viral and cellular factors involved in ' 'neuroinvasiveness and neuropathogenesis', 'author': 'Desforges', 'doi-asserted-by': 'crossref', 'first-page': '145', 'journal-title': 'Virus Res.', 'key': '10.1016/j.jpsychores.2023.111389_bb0010', 'volume': '194', 'year': '2014'}, { 'DOI': '10.1186/s13054-020-02882-x', 'article-title': 'COVID-19: ICU delirium management during SARS-CoV-2 pandemic', 'author': 'Kotfis', 'doi-asserted-by': 'crossref', 'first-page': '1', 'issue': '1', 'journal-title': 'Crit. Care', 'key': '10.1016/j.jpsychores.2023.111389_bb0015', 'volume': '24', 'year': '2020'}, { 'DOI': '10.15585/mmwr.mm6930e1', 'article-title': 'Symptom duration and risk factors for delayed return to usual health ' 'among outpatients with COVID-19 in a multistate health care systems ' 'network - United States, march-June 2020', 'author': 'Tenforde', 'doi-asserted-by': 'crossref', 'first-page': '993', 'issue': '30', 'journal-title': 'MMWR Morb. Mortal. Wkly Rep.', 'key': '10.1016/j.jpsychores.2023.111389_bb0020', 'volume': '69', 'year': '2020'}, { 'DOI': '10.1001/jama.2020.12603', 'article-title': 'Group ftGAC-P-ACS: persistent symptoms in patients after acute COVID-19', 'author': 'Carfì', 'doi-asserted-by': 'crossref', 'first-page': '603', 'issue': '6', 'journal-title': 'JAMA', 'key': '10.1016/j.jpsychores.2023.111389_bb0025', 'volume': '324', 'year': '2020'}, { 'DOI': '10.1016/j.bbi.2021.12.020', 'article-title': 'Fatigue and cognitive impairment in post-COVID-19 syndrome: a ' 'systematic review and meta-analysis', 'author': 'Ceban', 'doi-asserted-by': 'crossref', 'first-page': '93', 'journal-title': 'Brain Behav. Immun.', 'key': '10.1016/j.jpsychores.2023.111389_bb0030', 'volume': '101', 'year': '2022'}, { 'DOI': '10.1016/j.jns.2022.120162', 'article-title': 'Mid and long-term neurological and neuropsychiatric manifestations of ' 'post-COVID-19 syndrome: a meta-analysis', 'author': 'Premraj', 'doi-asserted-by': 'crossref', 'journal-title': 'J. Neurol. Sci.', 'key': '10.1016/j.jpsychores.2023.111389_bb0035', 'volume': '434', 'year': '2022'}, { 'DOI': '10.1016/j.bbi.2020.04.027', 'article-title': 'Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? ' 'Neuropsychiatric symptoms and potential immunologic mechanisms', 'author': 'Troyer', 'doi-asserted-by': 'crossref', 'first-page': '34', 'journal-title': 'Brain Behav. Immun.', 'key': '10.1016/j.jpsychores.2023.111389_bb0040', 'volume': '87', 'year': '2020'}, { 'DOI': '10.1016/S2215-0366(20)30287-X', 'article-title': 'Neurological and neuropsychiatric complications of COVID-19 in 153 ' 'patients: a UK-wide surveillance study', 'author': 'Varatharaj', 'doi-asserted-by': 'crossref', 'first-page': '875', 'issue': '10', 'journal-title': 'Lancet Psychiatry', 'key': '10.1016/j.jpsychores.2023.111389_bb0045', 'volume': '7', 'year': '2020'}, { 'DOI': '10.1016/j.bbi.2020.05.048', 'article-title': 'COVID-19 pandemic and mental health consequences: systematic review of ' 'the current evidence', 'author': 'Vindegaard', 'doi-asserted-by': 'crossref', 'first-page': '531', 'journal-title': 'Brain Behav. Immun.', 'key': '10.1016/j.jpsychores.2023.111389_bb0050', 'volume': '89', 'year': '2020'}, { 'article-title': 'Neurology and neuropsychiatry of COVID-19: a systematic review and ' 'meta-analysis of the early literature reveals frequent CNS ' 'manifestations and key emerging narratives', 'author': 'Rogers', 'first-page': '932', 'issue': '9', 'journal-title': 'J. Neurol. Neurosurg. Psychiatry', 'key': '10.1016/j.jpsychores.2023.111389_bb0055', 'volume': '92', 'year': '2021'}, { 'DOI': '10.1053/j.gastro.2020.05.098', 'article-title': 'Association between famotidine use and COVID-19 severity in Hong Kong: ' 'a territory-wide study', 'author': 'Cheung', 'doi-asserted-by': 'crossref', 'first-page': '1898', 'issue': '5', 'journal-title': 'Gastroenterology', 'key': '10.1016/j.jpsychores.2023.111389_bb0060', 'volume': '160', 'year': '2021'}, { 'DOI': '10.14309/ajg.0000000000001153', 'article-title': 'Comparative effectiveness of famotidine in hospitalized COVID-19 ' 'patients', 'author': 'Shoaibi', 'doi-asserted-by': 'crossref', 'first-page': '692', 'issue': '4', 'journal-title': 'Off. J. American Coll. Gastroenterol. ACG', 'key': '10.1016/j.jpsychores.2023.111389_bb0065', 'volume': '116', 'year': '2021'}, { 'DOI': '10.1053/j.gastro.2020.10.011', 'article-title': 'Famotidine use is not associated with 30-day mortality: a coarsened ' 'exact match study in 7158 hospitalized patients with coronavirus ' 'disease 2019 from a large healthcare system', 'author': 'Yeramaneni', 'doi-asserted-by': 'crossref', 'first-page': '919', 'issue': '3', 'journal-title': 'Gastroenterology', 'key': '10.1016/j.jpsychores.2023.111389_bb0070', 'volume': '160', 'year': '2021'}, { 'DOI': '10.1136/gutjnl-2020-323668', 'article-title': 'Proton pump inhibitor or famotidine use and severe COVID-19 disease: a ' 'propensity score-matched territory-wide study', 'author': 'Zhou', 'doi-asserted-by': 'crossref', 'first-page': '2012', 'issue': '10', 'journal-title': 'Gut', 'key': '10.1016/j.jpsychores.2023.111389_bb0075', 'volume': '70', 'year': '2021'}, { 'DOI': '10.1053/j.gastro.2020.05.053', 'article-title': 'Famotidine use is associated with improved clinical outcomes in ' 'hospitalized COVID-19 patients: a propensity score matched ' 'retrospective cohort study', 'author': 'Freedberg', 'doi-asserted-by': 'crossref', 'first-page': '1129', 'issue': '3', 'journal-title': 'Gastroenterology', 'key': '10.1016/j.jpsychores.2023.111389_bb0080', 'volume': '159', 'year': '2020'}, { 'DOI': '10.1136/gutjnl-2020-321852', 'article-title': 'Famotidine use and quantitative symptom tracking for COVID-19 in ' 'non-hospitalised patients: a case series', 'author': 'Janowitz', 'doi-asserted-by': 'crossref', 'first-page': '1592', 'issue': '9', 'journal-title': 'Gut', 'key': '10.1016/j.jpsychores.2023.111389_bb0085', 'volume': '69', 'year': '2020'}, { 'DOI': '10.1136/gutjnl-2022-326952', 'article-title': 'Oral famotidine versus placebo in non-hospitalised patients with ' 'COVID-19: a randomised, double-blind, data-intense, phase 2 clinical ' 'trial', 'author': 'Christina', 'doi-asserted-by': 'crossref', 'first-page': '879', 'issue': '5', 'journal-title': 'Gut', 'key': '10.1016/j.jpsychores.2023.111389_bb0090', 'volume': '71', 'year': '2022'}, { 'article-title': 'Case report: famotidine for neuropsychiatric symptoms in COVID-19', 'author': 'Alper', 'first-page': '936', 'journal-title': 'Front. Med.', 'key': '10.1016/j.jpsychores.2023.111389_bb0095', 'year': '2020'}, { 'DOI': '10.1097/00002826-199619040-00007', 'article-title': 'An open-label study of the therapeutic efficacy of high-dose famotidine ' 'adjuvant pharmacotherapy in schizophrenia: preliminary evidence for ' 'treatment efficacy', 'author': 'Rosse', 'doi-asserted-by': 'crossref', 'first-page': '341', 'issue': '4', 'journal-title': 'Clin. Neuropharmacol.', 'key': '10.1016/j.jpsychores.2023.111389_bb0100', 'volume': '19', 'year': '1996'}, { 'DOI': '10.1016/S0924-9338(97)83302-0', 'article-title': 'Famotidine: a supplemental drug for the treatment of schizophrenia', 'author': 'Dannon', 'doi-asserted-by': 'crossref', 'first-page': '263', 'issue': '5', 'journal-title': 'Eur. Psychiatr.', 'key': '10.1016/j.jpsychores.2023.111389_bb0105', 'volume': '12', 'year': '1997'}, { 'DOI': '10.1097/00002826-199312000-00005', 'article-title': 'Famotidine adjunctive pharmacotherapy for schizophrenia: preliminary ' 'data', 'author': 'Deutsch', 'doi-asserted-by': 'crossref', 'first-page': '518', 'issue': '6', 'journal-title': 'Clin. Neuropharmacol.', 'key': '10.1016/j.jpsychores.2023.111389_bb0110', 'volume': '16', 'year': '1993'}, { 'DOI': '10.1097/JCP.0b013e3182970490', 'article-title': 'A randomized clinical trial of histamine 2 receptor antagonism in ' 'treatment-resistant schizophrenia', 'author': 'Meskanen', 'doi-asserted-by': 'crossref', 'first-page': '472', 'issue': '4', 'journal-title': 'J. Clin. Psychopharmacol.', 'key': '10.1016/j.jpsychores.2023.111389_bb0115', 'volume': '33', 'year': '2013'}, { 'DOI': '10.1016/0197-4580(95)00049-K', 'article-title': 'Delayed onset of Alzheimer’s disease with nonsteroidal ' 'anti-inflammatory and histamine H2 blocking drugs', 'author': 'Breitner', 'doi-asserted-by': 'crossref', 'first-page': '523', 'issue': '4', 'journal-title': 'Neurobiol. Aging', 'key': '10.1016/j.jpsychores.2023.111389_bb0120', 'volume': '16', 'year': '1995'}, { 'DOI': '10.1212/WNL.54.11.2066', 'article-title': 'Reduced prevalence of AD in users of NSAIDs and H2 receptor ' 'antagonists: the Cache County study', 'author': 'Anthony', 'doi-asserted-by': 'crossref', 'first-page': '2066', 'issue': '11', 'journal-title': 'Neurology', 'key': '10.1016/j.jpsychores.2023.111389_bb0125', 'volume': '54', 'year': '2000'}, { 'DOI': '10.3389/fphar.2021.633680', 'article-title': 'COVID-19: famotidine, histamine, mast cells, and mechanisms', 'author': 'Malone', 'doi-asserted-by': 'crossref', 'journal-title': 'Front. Pharmacol.', 'key': '10.1016/j.jpsychores.2023.111389_bb0130', 'volume': '12', 'year': '2021'}, { 'article-title': 'Famotidine against SARS-CoV2: a hope or hype?', 'author': 'Ghosh', 'first-page': '1797', 'key': '10.1016/j.jpsychores.2023.111389_bb0135', 'series-title': 'Mayo Clinic Proceedings', 'year': '2020'}, { 'DOI': '10.1001/jama.1993.03500180078038', 'article-title': 'Population-based norms for the Mini-mental state examination by age and ' 'educational level', 'author': 'Crum', 'doi-asserted-by': 'crossref', 'first-page': '2386', 'issue': '18', 'journal-title': 'JAMA', 'key': '10.1016/j.jpsychores.2023.111389_bb0140', 'volume': '269', 'year': '1993'}, { 'DOI': '10.1111/j.1532-5415.2005.53221.x', 'article-title': 'The Montreal cognitive assessment, MoCA: a brief screening tool for ' 'mild cognitive impairment', 'author': 'Nasreddine', 'doi-asserted-by': 'crossref', 'first-page': '695', 'issue': '4', 'journal-title': 'J. Am. Geriatr. Soc.', 'key': '10.1016/j.jpsychores.2023.111389_bb0145', 'volume': '53', 'year': '2005'}, { 'DOI': '10.1007/s10072-021-05630-3', 'article-title': 'Screening for cognitive sequelae of SARS-CoV-2 infection: a comparison ' 'between the Mini-mental state examination (MMSE) and the Montreal ' 'cognitive assessment (MoCA)', 'author': 'Aiello', 'doi-asserted-by': 'crossref', 'first-page': '81', 'issue': '1', 'journal-title': 'Neurol. Sci.', 'key': '10.1016/j.jpsychores.2023.111389_bb0150', 'volume': '43', 'year': '2022'}, { 'DOI': '10.1371/journal.pone.0246590', 'article-title': 'COVID-19 cognitive deficits after respiratory assistance in the ' 'subacute phase: a COVID-rehabilitation unit experience', 'author': 'Alemanno', 'doi-asserted-by': 'crossref', 'issue': '2', 'journal-title': 'PLoS One', 'key': '10.1016/j.jpsychores.2023.111389_bb0155', 'volume': '16', 'year': '2021'}, { 'DOI': '10.1046/j.1365-2710.2000.00295.x', 'article-title': 'Double-blind randomized controlled trial of baclofen vs. clonidine in ' 'the treatment of opiates withdrawal', 'author': 'Akhondzadeh', 'doi-asserted-by': 'crossref', 'first-page': '347', 'issue': '5', 'journal-title': 'J. Clin. Pharm. Ther.', 'key': '10.1016/j.jpsychores.2023.111389_bb0160', 'volume': '25', 'year': '2000'}, { 'DOI': '10.1016/j.jad.2016.05.076', 'article-title': 'Efficacy and safety of oral ketamine versus diclofenac to alleviate ' 'mild to moderate depression in chronic pain patients: a double-blind, ' 'randomized, controlled trial', 'author': 'Jafarinia', 'doi-asserted-by': 'crossref', 'first-page': '1', 'journal-title': 'J. Affect. Disord.', 'key': '10.1016/j.jpsychores.2023.111389_bb0165', 'volume': '204', 'year': '2016'}, { 'article-title': 'Comparison of saffron versus fluoxetine in treatment of mild to ' 'moderate postpartum depression: a double-blind, randomized clinical ' 'trial', 'author': 'Kashani', 'first-page': '64', 'issue': '2', 'journal-title': 'Pharmacopsychiatry', 'key': '10.1016/j.jpsychores.2023.111389_bb0170', 'volume': '50', 'year': '2017'}, { 'DOI': '10.1111/j.1365-2125.1987.tb03261.x', 'article-title': 'CSF concentrations of famotidine', 'author': 'Kagevi', 'doi-asserted-by': 'crossref', 'first-page': '849', 'issue': '6', 'journal-title': 'Br. J. Clin. Pharmacol.', 'key': '10.1016/j.jpsychores.2023.111389_bb0175', 'volume': '24', 'year': '1987'}, { 'article-title': 'Efficacy and tolerability of histamine-2 receptor antagonist adjunction ' 'of antipsychotic treatment in schizophrenia: a meta-analysis of ' 'randomized placebo-controlled trials', 'author': 'Kishi', 'first-page': '30', 'issue': '1', 'journal-title': 'Pharmacopsychiatry', 'key': '10.1016/j.jpsychores.2023.111389_bb0180', 'volume': '48', 'year': '2015'}, { 'DOI': '10.1111/j.1472-8206.2009.00810.x', 'article-title': 'Hepatoprotective, antinociceptive and antioxidant activities of ' 'cimetidine, ranitidine and famotidine as histamine H2 receptor ' 'antagonists', 'author': 'Ahmadi', 'doi-asserted-by': 'crossref', 'first-page': '72', 'issue': '1', 'journal-title': 'Fundam. Clin. Pharmacol.', 'key': '10.1016/j.jpsychores.2023.111389_bb0185', 'volume': '25', 'year': '2011'}, { 'DOI': '10.1016/j.jbc.2021.100925', 'article-title': 'Famotidine inhibits toll-like receptor 3-mediated inflammatory ' 'signaling in SARS-CoV-2 infection', 'author': 'Mukherjee', 'doi-asserted-by': 'crossref', 'issue': '2', 'journal-title': 'J. Biol. Chem.', 'key': '10.1016/j.jpsychores.2023.111389_bb0190', 'volume': '297', 'year': '2021'}, { 'DOI': '10.1016/S0197-4580(97)00010-9', 'article-title': 'Histamine H2 blocking drugs and the risk for Alzheimer’s disease: the ' 'Rotterdam study', 'author': 'Launer', 'doi-asserted-by': 'crossref', 'first-page': '257', 'issue': '2', 'journal-title': 'Neurobiol. Aging', 'key': '10.1016/j.jpsychores.2023.111389_bb0195', 'volume': '18', 'year': '1997'}, { 'DOI': '10.1002/pds.952', 'article-title': 'Histamine2 receptor antagonist use and decline in cognitive function ' 'among community dwelling elderly', 'author': 'Hanlon', 'doi-asserted-by': 'crossref', 'first-page': '781', 'issue': '11', 'journal-title': 'Pharmacoepidemiol. Drug Saf.', 'key': '10.1016/j.jpsychores.2023.111389_bb0200', 'volume': '13', 'year': '2004'}, { 'DOI': '10.1111/j.1532-5415.2010.03275.x', 'article-title': 'Histamine-2 receptor antagonist use and incident dementia in an older ' 'cohort', 'author': 'Gray', 'doi-asserted-by': 'crossref', 'first-page': '251', 'issue': '2', 'journal-title': 'J. Am. Geriatr. Soc.', 'key': '10.1016/j.jpsychores.2023.111389_bb0205', 'volume': '59', 'year': '2011'}, { 'DOI': '10.1212/WNL.59.6.880', 'article-title': 'Cache County study I: reduced incidence of AD with NSAID but not H2 ' 'receptor antagonists: the Cache County study', 'author': 'Zandi', 'doi-asserted-by': 'crossref', 'first-page': '880', 'issue': '6', 'journal-title': 'Neurology', 'key': '10.1016/j.jpsychores.2023.111389_bb0210', 'volume': '59', 'year': '2002'}, { 'DOI': '10.1111/j.1532-5415.2007.01270.x', 'article-title': 'The association between cognition and histamine-2 receptor antagonists ' 'in African Americans', 'author': 'Boustani', 'doi-asserted-by': 'crossref', 'first-page': '1248', 'issue': '8', 'journal-title': 'J. Am. Geriatr. Soc.', 'key': '10.1016/j.jpsychores.2023.111389_bb0215', 'volume': '55', 'year': '2007'}, { 'article-title': 'Gastric acid suppressants and cognitive decline in people with or ' 'without cognitive impairment', 'author': 'Wu', 'issue': '1', 'journal-title': 'Alzheimer’s & Dementia: Translat. Res. Clin. Intervent.', 'key': '10.1016/j.jpsychores.2023.111389_bb0220', 'volume': '8', 'year': '2022'}, { 'DOI': '10.1016/j.cbi.2019.108823', 'article-title': 'Famotidine has a neuroprotective effect on MK-801 induced toxicity via ' 'the Akt/GSK-3beta/beta-catenin signaling pathway in the SH-SY5Y cell ' 'line', 'author': 'Unal', 'doi-asserted-by': 'crossref', 'journal-title': 'Chem. Biol. Interact.', 'key': '10.1016/j.jpsychores.2023.111389_bb0225', 'volume': '314', 'year': '2019'}, { 'DOI': '10.3390/cells10020262', 'article-title': 'Mechanisms and therapeutic implications of GSK-3 in treating ' 'neurodegeneration', 'author': 'Rippin', 'doi-asserted-by': 'crossref', 'issue': '2', 'journal-title': 'Cells', 'key': '10.1016/j.jpsychores.2023.111389_bb0230', 'volume': '10', 'year': '2021'}, { 'DOI': '10.5455/PBS.20200330095749', 'article-title': 'Famotidine improved schizophrenia-like behaviors in acute ketamine ' 'model of schizophrenia in rats', 'author': 'Gokhan', 'doi-asserted-by': 'crossref', 'first-page': '45', 'issue': '2', 'journal-title': 'PBS', 'key': '10.1016/j.jpsychores.2023.111389_bb0235', 'volume': '10', 'year': '2020'}, { 'DOI': '10.1016/j.cell.2022.06.008', 'article-title': 'Mild respiratory COVID can cause multi-lineage neural cell and myelin ' 'dysregulation', 'author': 'Fernández-Castañeda', 'doi-asserted-by': 'crossref', 'first-page': '2452', 'issue': '14', 'journal-title': 'Cell', 'key': '10.1016/j.jpsychores.2023.111389_bb0240', 'volume': '185', 'year': '2022'}, { 'DOI': '10.1186/s10020-022-00483-8', 'article-title': 'Famotidine activates the vagus nerve inflammatory reflex to attenuate ' 'cytokine storm', 'author': 'Yang', 'doi-asserted-by': 'crossref', 'first-page': '57', 'issue': '1', 'journal-title': 'Mol. Med.', 'key': '10.1016/j.jpsychores.2023.111389_bb0245', 'volume': '28', 'year': '2022'}, { 'DOI': '10.1016/j.apsb.2020.02.008', 'article-title': 'Analysis of therapeutic targets for SARS-CoV-2 and discovery of ' 'potential drugs by computational methods', 'author': 'Wu', 'doi-asserted-by': 'crossref', 'first-page': '766', 'issue': '5', 'journal-title': 'Acta Pharm. Sin. B', 'key': '10.1016/j.jpsychores.2023.111389_bb0250', 'volume': '10', 'year': '2020'}, { 'DOI': '10.1038/s41577-020-0321-6', 'article-title': 'The potential danger of suboptimal antibody responses in COVID-19', 'author': 'Iwasaki', 'doi-asserted-by': 'crossref', 'first-page': '339', 'issue': '6', 'journal-title': 'Nat. Rev. Immunol.', 'key': '10.1016/j.jpsychores.2023.111389_bb0255', 'volume': '20', 'year': '2020'}, { 'DOI': '10.14309/ajg.0000000000000832', 'article-title': 'Impact of famotidine use on clinical outcomes of hospitalized patients ' 'with COVID-19', 'author': 'Mather', 'doi-asserted-by': 'crossref', 'first-page': '1617', 'issue': '10', 'journal-title': 'Am. J. Gastroenterol.', 'key': '10.1016/j.jpsychores.2023.111389_bb0260', 'volume': '115', 'year': '2020'}, { 'DOI': '10.1371/journal.pone.0259514', 'article-title': 'Effect of famotidine on hospitalized patients with COVID-19: a ' 'systematic review and meta-analysis', 'author': 'Chiu', 'doi-asserted-by': 'crossref', 'issue': '11', 'journal-title': 'PLoS One', 'key': '10.1016/j.jpsychores.2023.111389_bb0265', 'volume': '16', 'year': '2021'}, { 'DOI': '10.1007/s10620-021-06872-z', 'article-title': 'Does famotidine reduce the risk of progression to severe disease, ' 'death, and intubation for COVID-19 patients? A systemic review and ' 'meta-analysis', 'author': 'Sun', 'doi-asserted-by': 'crossref', 'first-page': '3929', 'issue': '11', 'journal-title': 'Dig. Dis. Sci.', 'key': '10.1016/j.jpsychores.2023.111389_bb0270', 'volume': '66', 'year': '2021'}, { 'DOI': '10.1053/j.gastro.2021.02.028', 'article-title': 'Lack of consistent associations between pharmacologic gastric acid ' 'suppression and adverse outcomes in patients with coronavirus disease ' '2019: meta-analysis of observational studies', 'author': 'Kamal', 'doi-asserted-by': 'crossref', 'first-page': '2588', 'issue': '7', 'journal-title': 'Gastroenterology', 'key': '10.1016/j.jpsychores.2023.111389_bb0275', 'volume': '160', 'year': '2021'}, { 'DOI': '10.3389/fphar.2019.00299', 'article-title': 'Histamine and delirium: current opinion', 'author': 'Chazot', 'doi-asserted-by': 'crossref', 'first-page': '299', 'journal-title': 'Front. Pharmacol.', 'key': '10.1016/j.jpsychores.2023.111389_bb0280', 'volume': '10', 'year': '2019'}, { 'DOI': '10.1159/000341873', 'article-title': 'Comparison and analysis of delirium induced by histamine H2 receptor ' 'antagonists and proton pump inhibitors in cancer patients', 'author': 'Fujii', 'doi-asserted-by': 'crossref', 'first-page': '409', 'issue': '2', 'journal-title': 'Case Rep. Oncol.', 'key': '10.1016/j.jpsychores.2023.111389_bb0285', 'volume': '5', 'year': '2012'}, { 'article-title': 'Reduction in the rate of postoperative delirium by switching from ' 'famotidine to omeprazole in Japanese hepatectomized recipients', 'author': 'Yamasaki', 'first-page': '1', 'issue': '1', 'journal-title': 'J. Pharmaceut. Health Care Sci.', 'key': '10.1016/j.jpsychores.2023.111389_bb0290', 'volume': '5', 'year': '2019'}, { 'article-title': 'The prevalence and long-term health effects of long Covid among ' 'hospitalised and non-hospitalised populations: a systematic review and ' 'meta-analysis', 'author': 'O’Mahoney', 'journal-title': 'eClinicalMedicine', 'key': '10.1016/j.jpsychores.2023.111389_bb0295', 'volume': '55', 'year': '2023'}, { 'article-title': 'Playing catch with long COVID – Understanding a new disease', 'author': 'Berg', 'first-page': '25', 'journal-title': 'Lancet Reg. Health – Europe', 'key': '10.1016/j.jpsychores.2023.111389_bb0300', 'year': '2023'}], 'reference-count': 59, 'references-count': 59, 'relation': {}, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S0022399923002465'}}, 'score': 1, 'short-title': [], 'source': 'Crossref', 'subject': ['Psychiatry and Mental health', 'Clinical Psychology'], 'subtitle': [], 'title': 'Effect of famotidine on cognitive and behavioral dysfunctions induced in post-COVID-19 ' 'infection: A randomized, double-blind, and placebo-controlled study', 'type': 'journal-article', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'volume': '172'}